Literature DB >> 16928716

Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: Effect of age related factors and service organisation.

M J Connolly1, D Lowe, K Anstey, H S R Hosker, M G Pearson, C M Roberts.   

Abstract

BACKGROUND: Exacerbations of chronic obstructive pulmonary disease (COPD) have a high rate of mortality which gets worse with advancing age. It is unknown whether this is due to age related deficiencies in process of care. A study was undertaken in patients with COPD exacerbations admitted to UK hospitals to assess whether there were age related differences in the process of care that might affect outcome, and whether different models of care affected process and outcome.
METHODS: 247 hospital units audited activity and outcomes (inpatient death, death within 90 days, length of stay (LOS), readmission within 90 days) for 40 consecutive COPD exacerbation admissions in autumn 2003. Logistic regression methods were used to assess relationships between process and outcome at p < 0.001.
RESULTS: 7514 patients (36% aged > or = 75 years) were included. Patients aged > or = 75 years were less likely to have blood gases documented, to have FEV1 recorded, or to be given systemic corticosteroids. Those admitted under care of the elderly (CoE) physicians were less likely to enter early discharge schemes or to receive non-invasive ventilation when acidotic. Overall inpatient and 90 day mortality was 7.4% and 15.3%, respectively. Inpatient and 90 day adjusted odds mortality rates for those aged > or = 85 years (versus < or = 65 years) were 3.25 and 2.54, respectively. Mortality was unaffected by admitting physician (CoE v general v respiratory). Age predicted LOS but not readmission. Age related deficiencies in process of care did not predict inpatient or 90 day mortality, readmission, or LOS.
CONCLUSIONS: Management of COPD exacerbations varies with age in UK hospitals. Inpatient and 90 day mortality is approximately three times higher in very elderly patients with a COPD exacerbation than in younger patients. Age related deficiencies in the process of care were not associated with mortality, but it is likely that they represent poorer quality of care and patient experience. Recommended standards of care should be applied equally to elderly patients with an exacerbation of COPD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16928716      PMCID: PMC2104767          DOI: 10.1136/thx.2005.054924

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  Patients' and carers' preferences in two models of care for acute exacerbations of COPD: results of a randomised controlled trial.

Authors:  J C Ojoo; T Moon; S McGlone; K Martin; E D Gardiner; M A Greenstone; A H Morice
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

2.  Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  C M Roberts; D Lowe; C E Bucknall; I Ryland; Y Kelly; M G Pearson
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

3.  Audit of acute admissions of COPD: standards of care and management in the hospital setting.

Authors:  C M Roberts; I Ryland; D Lowe; Y Kelly; C E Bucknall; M G Pearson
Journal:  Eur Respir J       Date:  2001-03       Impact factor: 16.671

4.  Recent trends in physician diagnosed COPD in women and men in the UK.

Authors:  J B Soriano; W C Maier; P Egger; G Visick; B Thakrar; J Sykes; N B Pride
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

Review 5.  Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review.

Authors:  J M Singh; V A Palda; M B Stanbrook; K R Chapman
Journal:  Arch Intern Med       Date:  2002 Dec 9-23

6.  UK National COPD Audit 2003: Impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation.

Authors:  L C Price; D Lowe; H S R Hosker; K Anstey; M G Pearson; C M Roberts
Journal:  Thorax       Date:  2006-01-31       Impact factor: 9.139

7.  "Hospital at home" versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial.

Authors:  L Davies; M Wilkinson; S Bonner; P M Calverley; R M Angus
Journal:  BMJ       Date:  2000-11-18

8.  Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.

Authors:  François Maltais; Juliette Ostinelli; Jean Bourbeau; André Bernard Tonnel; Nadine Jacquemet; Jennifer Haddon; Michel Rouleau; Mohamed Boukhana; Jean Benoît Martinot; Pierre Duroux
Journal:  Am J Respir Crit Care Med       Date:  2002-03-01       Impact factor: 21.405

9.  Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients.

Authors:  C Hernandez; A Casas; J Escarrabill; J Alonso; J Puig-Junoy; E Farrero; G Vilagut; B Collvinent; R Rodriguez-Roisin; J Roca
Journal:  Eur Respir J       Date:  2003-01       Impact factor: 16.671

10.  Evidence for a link between mortality in acute COPD and hospital type and resources.

Authors:  C M Roberts; S Barnes; D Lowe; M G Pearson
Journal:  Thorax       Date:  2003-11       Impact factor: 9.139

View more
  29 in total

1.  Caring for the burden of COPD.

Authors:  P M A Calverley
Journal:  Thorax       Date:  2006-10       Impact factor: 9.139

2.  Characterization of Chronic Obstructive Pulmonary Disease Patients with a Long Length of Stay: A Retrospective Observational Cohort Study.

Authors:  Yasser Madani; Anita Saigal; Juno Sunny; Leila Morris; Robin H Johns
Journal:  Turk Thorac J       Date:  2017-10-01

3.  Early and Long-term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease Exacerbation.

Authors:  Liza Genao; Michael T Durheim; Xiaojuan Mi; Jamie L Todd; Heather E Whitson; Lesley H Curtis
Journal:  Ann Am Thorac Soc       Date:  2015-12

4.  Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.

Authors:  Andriana I Papaioannou; Elisavet Konstantelou; Anastasia Papaporfyriou; Konstantinos Bartziokas; Aris Spathis; Petros Bakakos; Stelios Loukides; Nikolaos Koulouris; Spyros Papiris; Konstantinos Kostikas
Journal:  Lung       Date:  2018-02-14       Impact factor: 2.584

5.  A Revised Treatment Approach for Hospitalized Patients with Eosinophilic and Neutrophilic Exacerbations of Chronic Obstructive Pulmonary Disease.

Authors:  Emine Aksoy; Sinem Güngör; Meltem Çoban Ağca; İpek Özmen; Dildar Duman; Nagihan Durmuş Koçak; Ülkü Aka Aktürk; Eylem Tunçay; Cüneyt Saltürk; Murat Yalçınsoy; Birsen Ocaklı; Zuhal Karakurt
Journal:  Turk Thorac J       Date:  2018-09-13

6.  Predictors of one-year mortality after hospitalization for an exacerbation of COPD.

Authors:  Cristóbal Esteban; Ady Castro-Acosta; Carlos Jose Alvarez-Martínez; Alberto Capelastegui; José Luis López-Campos; Francisco Pozo-Rodriguez
Journal:  BMC Pulm Med       Date:  2018-01-25       Impact factor: 3.317

Review 7.  Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing.

Authors:  Preeti Gupta; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 8.  Acute exacerbations of chronic bronchitis in elderly patients: pathogenesis, diagnosis and management.

Authors:  Don Hayes; Keith C Meyer
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

9.  Chronic obstructive pulmonary disease exacerbations and progression in relation to ambient air pollutants exposure.

Authors:  Miglena Doneva; Guenka Petrova; Daniela Petrova; Maria Kamusheva; Valentina Petkova; Konstantin Tachkov; Ventsislava Pencheva; Ognyan Georgiev
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

10.  Factors influencing the length of hospital stay among patients resident in Blackpool admitted with COPD: a cross-sectional study.

Authors:  Gabriel Agboado; Jonathan Peters; Lynn Donkin
Journal:  BMJ Open       Date:  2012-09-01       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.